CHRS

SEC source: 0001610717-23-000401 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,406

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F2 · balance_after: Includes 3,402 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001610717-23-000363 · form4.xml · derivative · entry 6

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 299,940 shares

Expires 2023-11-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The underlying shares subject to the option vested and became exercisable in successive, equal monthly installments over four years measured from July 20, 2013.

SEC source: 0001610717-23-000363 · form4.xml · nonDerivative · entry 3

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 731,693

F2 · kind: For the remaining part of the stock option, this represents a cashless exercise-and-hold transaction where only enough shares were sold to cover the exercise price, anticipated taxes and broker's fee, and the remaining shares were held by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $2.000 to $2.055. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001610717-23-000363 · form4.xml · nonDerivative · entry 2

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 954,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: For the remaining part of the stock option, this represents a cashless exercise-and-hold transaction where only enough shares were sold to cover the exercise price, anticipated taxes and broker's fee, and the remaining shares were held by the Reporting Person.

SEC source: 0001610717-23-000363 · form4.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 695,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: For part of the stock option, this represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price and anticipated taxes.

SEC source: 0001610717-23-000207 · form4.xml · derivative · entry 1

Ryan Michael Lee · CIK 0001985918 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 54,000 shares

Expires 2033-07-18

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from July 18, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000166 · form4.xml · derivative · entry 1

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000168 · form4.xml · derivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000167 · form4.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000165 · form4.xml · derivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000117 · form4.xml · derivative · entry 1

Newton Charles W. · CIK 0001866219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,250

Underlying: Common Stock · 38,250 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000122 · form4.xml · derivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,250

Underlying: Common Stock · 38,250 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000121 · form4.xml · derivative · entry 1

STOLPER MARK · CIK 0001281961 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,250

Underlying: Common Stock · 38,250 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000120 · form4.xml · derivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,250

Underlying: Common Stock · 38,250 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000119 · form4.xml · derivative · entry 1

TZOUMAKAS KIMBERLY JO · CIK 0001766666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,250

Underlying: Common Stock · 38,250 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001610717-23-000118 · form4.xml · derivative · entry 1

O'Donnell-Tormey Jill · CIK 0001927733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,250

Underlying: Common Stock · 38,250 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001140361-23-016453 · form4.xml · nonDerivative · entry 1

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,252

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F2 · balance_after: Includes 1,466 shares acquired on May 13, 2022, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001140361-23-016454 · form4.xml · nonDerivative · entry 1

Reider Paul · CIK 0001970033 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,053

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001140361-23-016457 · form4.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,361

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F2 · balance_after: Includes 1,316 shares acquired on May 13, 2022, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001140361-23-014545 · form4.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-03-27

F1 · derivative.exercise_date: 1. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-001207 · doc1.xml · nonDerivative · entry 1

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,243

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-001209 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,323

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-001211 · doc1.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 654,853

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-001210 · doc1.xml · nonDerivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,386

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-000892 · doc1.xml · nonDerivative · entry 2

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,323

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001567619-23-000892 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,925

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001567619-23-000765 · doc1.xml · nonDerivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,886

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F2 · balance_after: Includes 1 share acquired on November 15, 2022, pursuant to Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001567619-23-000698 · doc1.xml · derivative · entry 4

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 402,500

Underlying: Common Stock · 402,500 shares

Expires 2033-01-05

F4 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-000695 · doc1.xml · derivative · entry 2

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2033-01-04

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-000695 · doc1.xml · nonDerivative · entry 1

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,243

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001567619-23-000696 · doc1.xml · derivative · entry 2

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2033-01-04

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-000696 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,527

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F2 · balance_after: Includes 1 share acquired on November 15, 2022, pursuant to Coherus BioSciences, Inc. Employee Stock Purchase Plan.

SEC source: 0001567619-23-000698 · doc1.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 568,603

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001567619-23-000697 · doc1.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-01-04

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-23-000350 · doc1.xml · nonDerivative · entry 1

Lanfear Dennis M · CIK 0001420822 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 432,684

F1 · ownership.nature: These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.

SEC source: 0001567619-22-017242 · doc1.xml · derivative · entry 1

McMichael Bryan J · CIK 0001944868 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-09-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-011419 · doc1.xml · derivative · entry 1

O'Donnell-Tormey Jill · CIK 0001927733 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 54,000 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from May 18, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-009712 · doc1.xml · derivative · entry 1

Newton Charles W. · CIK 0001866219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 54,000 shares

Expires 2032-05-04

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from May 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-008114 · doc1.xml · nonDerivative · entry 1

Stilwell McDavid · CIK 0001851389 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,680

F1 · kind: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

F1 · shares: Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.

SEC source: 0001567619-22-008113 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,963

F1 · kind: Represents shares automatically withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

F1 · shares: Represents shares automatically withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

SEC source: 0001567619-22-005922 · doc1.xml · derivative · entry 3

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,994 shares

Expires 2022-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The underlying shares subject to the option are fully vested and exercisable.

SEC source: 0001567619-22-005922 · doc1.xml · nonDerivative · entry 2

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

SEC source: 0001567619-22-005922 · doc1.xml · nonDerivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,006

SEC source: 0001567619-22-002564 · doc1.xml · derivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,000

Underlying: Common Stock · 54,000 shares

Expires 2032-02-02

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from February 2, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-001114 · doc1.xml · nonDerivative · entry 2

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,421

F3 · shares: Represents the number of shares of common stock withheld to pay the related tax liability on RSUs that vested on January 11, 2022.

F4 · balance_after: Includes 91,249 RSUs.

SEC source: 0001567619-22-001114 · doc1.xml · nonDerivative · entry 1

Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,004

F1 · shares: Represents the number of shares of common stock withheld to pay the related tax liability on restricted stock units ("RSUs") that vested on January 10, 2022.

F2 · balance_after: Includes 101,666 RSUs.

SEC source: 0001567619-22-000920 · doc1.xml · derivative · entry 1

Wahlstrom Mats · CIK 0001459154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires 2032-01-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-000924 · doc1.xml · derivative · entry 1

STOLPER MARK · CIK 0001281961 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires 2032-01-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-000925 · doc1.xml · derivative · entry 1

HEALY JAMES · CIK 0001245624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires 2032-01-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

SEC source: 0001567619-22-000923 · doc1.xml · derivative · entry 1

TZOUMAKAS KIMBERLY JO · CIK 0001766666 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires 2032-01-07

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.